When their two-year-old son was diagnosed with Systemic Juvenile Idiopathic Arthritis, Todd and Linsey Hyatt of Pearland, TX said, “Little kids don’t get arthritis; this has to be wrong.” But it wasn’t wrong. Tucker Beau, now six, grew up with intense joint pain in his knees, feet, ankles, hips, fingers, elbows, back and wrists. “It makes my heart feel like it’s on fire,” he says of his disease. His parents wanted to explore all possible treatment options for their son, so when they heard about stem cell therapy and Houston-based Celltex, they knew they had to give it a try. Find out more about Tucker Beau’s story, and hear from his parents and Tucker Beau himself in the video below.
The following is a review from Tucker Beau’s mother, Linsey Hyatt, updating Celltex on Tucker Beau’s progress after receiving stem cell injections for Systemic Juvenile Idiopathic Arthritis.
December 2nd, 2014
Dr. Salazar and Dr. Ana,
I would like to thank you for the help and support you have shown to Tucker Beau and our family. I am writing this email to update you Tucker Beau’s health status now that he has received 675 million of his own stem cells.
Tucker Beau’s health continues to improve each day. He has increased energy and appetite, his joints are looking better everyday, and we no longer need to wheel him round in his stroller. He has now gained 7 lbs in weight and grown 1 ½ inches. We have an upcoming appointment with Dr. Muscal this month. At this appointment, Dr. Muscal would like to discuss reducing his Actemra infusions from every two weeks to every three. He will start with the slow reduction of Actemra and continue with his current maintenance doses methotrexate, prednisone and naproxen.
Before Celltex stem cells, Tucker Beau’s treating physicians were in a quandary. His appetite was so diminished that he was heading into failure to thrive mode. Additionally, his flare-ups were not being controlled by the Actemra methotrexate, prednisone and naproxen regimen. The next step was to probably introduce an NG/Tube feeds and discuss big gun chemos such a rituximab.
Todd and my opinion is that the Celltex stem cells have slowed the aggression of Tucker Beau’s disease, whereby his existing, and soon to be reduced, medications can manage the disease without going to more aggressive treatments. We no longer see that look of pain on our child’s face. He is growing, eating, and able to run and play like a normal child. Thank you for giving our child the chance to live a normal life. We are excited to see how he continues to improve now since the November infusions and will keep you updated.
View more stem cell therapy testimonials
Celltex Therapeutics Corporation is a Houston-based biotechnology company founded in 2011 by David Eller and Dr. Stanley Jones, an internationally-recognized spine surgeon, to initiate breakthroughs in regenerative medicine through adult stem cells. Eller is a graduate of Texas A&M University, who served two terms as Chairman of the Board of Regents and also served as Chancellor of The Texas A&M University System for a short period. It was at Texas A&M University that his passion for bioscience took flight, leading him to establish the Institute of Biosciences and Technology during his six year term on the Texas A&M University System Board of Regents.
Celltex uses proprietary technology to isolate, multiply and store autologous, adult (one’s own) mesenchymal stem cells (MSCs) to be used for regenerative therapy in a number of conditions including vascular, autoimmune and degenerative diseases, which is why Sarah was a great candidate for stem cell therapy.
Find Out More
For more information about Celltex and the process of stem cell banking or to review some frequently asked questions about stem cell therapy, please visit the pages below:
If you would like to speak to a Celltex client services representative about banking your stem cells, please visit the Getting Started page or call (713) 590-1000.